| 注册
首页|期刊导航|中国医院用药评价与分析|滋肾育胎丸联合地屈孕酮片治疗早期先兆流产的疗效观察

滋肾育胎丸联合地屈孕酮片治疗早期先兆流产的疗效观察

林洁娜 廖秀玲 郭惠娟

中国医院用药评价与分析2017,Vol.17Issue(4):459-461,3.
中国医院用药评价与分析2017,Vol.17Issue(4):459-461,3.DOI:10.14009/j.issn.1672-2124.2017.04.010

滋肾育胎丸联合地屈孕酮片治疗早期先兆流产的疗效观察

Observation on Efficacy of Zishenyutai Pills Combined with Dydrogesterone Tablets in Treatment of Early Threatened Abortion

林洁娜 1廖秀玲 2郭惠娟3

作者信息

  • 1. 深圳市宝安区中医院药学部,广东 深圳 518133
  • 2. 深圳市宝安区中医院妇科,广东 深圳 518133
  • 3. 深圳市宝安区妇幼保健院药学部,广东 深圳 518105
  • 折叠

摘要

Abstract

OBJECTIVE:To probe into the clinical effects of Zishenyutai pills combined with Dydrogesterone tablets in treatment of early threatened abortion.METHODS: 150 patients with threatened abortion admitted into Shenzhen Bao'an District Traditional Chinese Medicine Hospital from Oct.2012 to Oct.2016 were selected to be divided into observation group and control group via the admission sequence, with 75 cases in each.The observation group was given Zishenyutai pills combined with Dydrogesterone tablets, while the control group received progesterone intramuscular injections.The efficacy and changes of whole high blood viscosity, HCT, FIB levels of two groups were compared between two groups before and after treatment.RESULTS: The total effective rate of observation group was 85.33%(64/75), and control group was 53.33%(50/75), the difference was statistically significant(P<0.05).After treatment, the FIB and whole high blood viscosity decreased significantly in both groups compared with before treatment, and the observation group was better than the control group, the difference was statistically significant(P<0.05).CONCLUSIONS: The effects of Zishenyutai pills combined with Dydrogesterone tablets in treatment of early threatened abortion is significant, which can significantly improve the hemodynamics of patients.

关键词

滋肾育胎丸/地屈孕酮片/早期先兆流产/效果评价

Key words

Zishenyutai pills/Dydrogesterone tablets/Early threatened abortion/Effect assessment

分类

医药卫生

引用本文复制引用

林洁娜,廖秀玲,郭惠娟..滋肾育胎丸联合地屈孕酮片治疗早期先兆流产的疗效观察[J].中国医院用药评价与分析,2017,17(4):459-461,3.

中国医院用药评价与分析

OACSTPCD

1672-2124

访问量0
|
下载量0
段落导航相关论文